Logo image of NSRX

NASUS PHARMA LTD (NSRX) Stock Income Statement

USA - NYSE Arca - NYSEARCA:NSRX - IL0012181553 - Common Stock

7 USD
-0.25 (-3.45%)
Last: 11/25/2025, 8:04:00 PM
7.31 USD
+0.31 (+4.43%)
After Hours: 11/11/2025, 5:35:42 PM

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2024
(2024-12-31)
2023
(2023-12-31)
2022
(2022-3-31)
Revenue
NSRX Revenue ChartNSRX Revenue over time chart
0.000.000.00
Operating Expenses
NSRX Operating Expenses ChartNSRX Operating Expenses over time chart
2.20K2.30K4.10K
Research and Development
NSRX Research and Development ChartNSRX Research and Development over time chart
300.00600.001.10K
Selling, General, and Administrative Expenses
NSRX Selling, General, and Administrative Expenses ChartNSRX Selling, General, and Administrative Expenses over time chart
700.00600.00900.00
Operating Income
NSRX Operating Income ChartNSRX Operating Income over time chart
-2.20K-2.30K-4.10K
Interest Income/Expense
NSRX Interest Income/Expense ChartNSRX Interest Income/Expense over time chart
-500.00200.00-100.00
Other Income/Expense
NSRX Other Income/Expense ChartNSRX Other Income/Expense over time chart
0.000.000.00
Income Before Taxes
NSRX Income Before Taxes ChartNSRX Income Before Taxes over time chart
-3.10K-2.00K-4.30K
Net Income
NSRX Net Income ChartNSRX Net Income over time chart
-3.10K-2.10K-3.40K
 
Per Share Data
EPS Diluted Total Ops
NSRX EPS Diluted Total Ops ChartNSRX EPS Diluted Total Ops over time chart
-0.00-0.00-0.00
 
Statistics

All data in USD

Charts

NSRX Income Statement data chartNSRX Revenue, Operating Income, Net Income and EBITDA ChartIncome Statements 2022 2023 2024 -1K -2K -3K -4K
NSRX Earnings Per Share (EPS) chartNSRX EPS Diluted and non-GAAP ChartEarnings Per Share 2022 2023 2024 0 0 0 0 0